申请人:King Abdulaziz University
公开号:US11311492B1
公开(公告)日:2022-04-26
A nanomedicine for the treatment of obesity comprising either noble metal nanoparticles having surface ligands comprising a mixture comprising (+)-catechin (2R,3S) and gingerol or particles of a carbon nanomaterial having an adsorbed mixture comprising (+)-catechin (2R,3S) and gingerol. Also provided are a method for making the noble metal nanomedicine and the carbon nanomedicine. The nanomedicine is used in a method of treating obesity.
本发明涉及一种用于治疗肥胖症的纳米药物,其成分包括:要么包含具有表面配体的贵金属纳米粒子,所述表面配体由混合物组成,所述混合物包括(+)-儿茶素(2R,3S)和姜酚;要么包含碳纳米材料颗粒,所述颗粒吸附有由混合物组成的混合物,所述混合物包括(+)-儿茶素(2R,3S)和姜酚。本发明还提供了一种制备所述贵金属纳米药物和碳纳米药物的方法。该纳米药物用于治疗肥胖症的方法。